CA14
Carbonic anhydrase 14
Also known as: CAH14_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9ULX7
- Gene
- CA14
- Ensembl
- ENSG00000118298
- Chromosome
- 1
- Canonical length
- 337 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA XIV is predicted to be a type I membrane protein and shares highest sequence similarity with the other transmembrane CA isoform, CA XII; however, they have different patterns of tissue-specific expression and thus may play different physiologic roles. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
337 residues, UniProt reviewed canonical sequence.
>Q9ULX7|CA14
1 MLFSALLLEV IWILAADGGQ HWTYEGPHGQ DHWPASYPEC GNNAQSPIDI QTDSVTFDPD
61 LPALQPHGYD QPGTEPLDLH NNGHTVQLSL PSTLYLGGLP RKYVAAQLHL HWGQKGSPGG
121 SEHQINSEAT FAELHIVHYD SDSYDSLSEA AERPQGLAVL GILIEVGETK NIAYEHILSH
181 LHEVRHKDQK TSVPPFNLRE LLPKQLGQYF RYNGSLTTPP CYQSVLWTVF YRRSQISMEQ
241 LEKLQGTLFS TEEEPSKLLV QNYRALQPLN QRMVFASFIQ AGSSYTTGEM LSLGVGILVG
301 CLCLLLAVYF IARKIRKKRL ENRKSVVFTS AQATTEALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CA14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 113 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 113 nTPM
- tongue: 44 nTPM
- spinal cord: 43 nTPM
- retina: 37 nTPM
- skeletal muscle: 32 nTPM
- midbrain: 22 nTPM
Single-cell type
- retinal pigment epithelial cells: 196 nCPM
- müller glia: 170 nCPM
- melanocytes: 74 nCPM
- oligodendrocytes: 23 nCPM
- cardiomyocytes: 11 nCPM
- hepatocytes: 8.7 nCPM
Immune cell
- naive B-cell: 0.6 nTPM
- plasmacytoid DC: 0.6 nTPM
- intermediate monocyte: 0.5 nTPM
- memory B-cell: 0.5 nTPM
- neutrophil: 0.5 nTPM
- eosinophil: 0.4 nTPM
Brain region
- choroid plexus: 61 nTPM
- white matter: 34 nTPM
- cerebellum: 24 nTPM
- medulla oblongata: 22 nTPM
- pons: 21 nTPM
- basal ganglia: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.46
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.24
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CA14 as an antibody target. Whether an autoantibody or antibody against CA14 could matter depends on whether native CA14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CA14 is annotated at the cell surface, where native CA14 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CA14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...